ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The interplay of transcriptional coregulator NUPR1 with SREBP1 promotes hepatocellular carcinoma progression via upregulation of lipogenesis

Wang, Yongjia; Zhang, Yuqin; Wang, Zixuan; Yu, Lu; Chen, Keli; Xie, Yuwen; Liu, Yang; Liang, Weijie; Zheng, Yilin; Zhan, Yizhi*; Ding, Yi*南方医科大学; 1; y
Cell Death Discovery2022-10-28DOI: 10.1038/s41420-022-01213-z
2被引4阅读
引用收藏
分享

摘要

Nuclear protein 1 (NUPR1) is a transcriptional coregulator that has been implicated in the development of various cancer types. In addition, de novo fatty acid synthesis plays a pivotal role in hepatocellular carcinoma (HCC) development. However, little is currently known on the role of NUPR1 in hepatocellular carcinoma. In this study, bioinformatics analysis was conducted to analyze the expression level, prognosis value and enriched pathways of NUPR1 in Liver Hepatocellular Carcinoma (LIHC). We found that NUPR1 was significantly upregulated in human hepatocellular carcinoma cells compared with normal hepatocytes from LIHC patients in TCGA cohorts and our patients. Kaplan-Meier analysis and COX proportional hazard progression model showed that high expression of NUPR1 was correlated with a poor prognosis of LIHC patients. CCK-8, EdU and colony formation assays were performed to explore the effect of NUPR1 on the proliferation of HCC cells, then wound healing and transwell migration assays were performed to evaluate the effects of NUPR1 on cell migration. Furthermore, subcutaneous xenograft models were established to study tumor growth. Results showed that NUPR1 overexpression correlated with a highly proliferative and aggressive phenotype. In addition, NUPR1 knockdown significantly inhibited hepatocellular carcinoma cell proliferation and migration in vitro and hindered tumorigenesis in vivo. Mechanistically, endogenous NUPR1 could interact with sterol regulatory element binding protein 1 (SREBP1) and upregulated lipogenic gene expression of fatty acid synthase (FASN), resulting in the accumulation of lipid content. Moreover, pharmacological or genetic blockade of the NUPR1-SREBP1/FASN pathway enhanced anticancer activity in vitro and in vivo. Overall, we identified a novel function of NUPR1 in regulating hepatocellular carcinoma progression via modulation of SREBP1-mediated de novo lipogenesis. Targeting NUPR1-SREBP1/FASN pathway may be a therapeutic alternative for hepatocellular carcinoma.

学科与关键词

关键词
GENE-EXPRESSIONMETABOLISMPROTEIN-1SYNTHASEGROWTHAXIS
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cell Death Discovery
发表日期
2022-10-28
卷期
第 8 卷, 第 1 期
页码
431
DOI
10.1038/s41420-022-01213-z
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81872470, 81903125]; Medical Scientific Research Foundation of Guangdong Province of China [A2020563]; President Foundation of Nanfang Hospital, Southern Medical University [2019B009]

作者

  • W

    Wang, Yongjia (第一作者)

    1 · southern med univ

  • Z

    Zhang, Yuqin

    southern med univ

查看全部 11 位作者收起作者
  • W

    Wang, Zixuan

    1 · southern med univ

  • Y

    Yu, Lu

    southern med univ

  • C

    Chen, Keli

    southern med univ

  • X

    Xie, Yuwen

    southern med univ

  • L

    Liu, Yang

    southern med univ

  • L

    Liang, Weijie

    southern med univ

  • Z

    Zheng, Yilin

    southern med univ

  • Z

    Zhan, Yizhi (通讯)

    southern med univ

  • D

    Ding, Yi (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417